Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis (vol 80, pg 789, 2023)

被引：0
|
作者：
不详
机构：
来源：
JAMA NEUROLOGY | 2023年 / 80卷 / 10期
关键词：
D O I：
10.1001/jamaneurol.2023.2958
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1119 / 1119
页数：1
相关论文
共 50 条
  • [21] Relapsing-remitting multiple sclerosis
    Flores, A
    Ochoa, E
    Zamora, S
    Barrientos, UN
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 214 (1-2) : 110 - 110
  • [22] Half-dose ocrelizumab in selected patients with relapsing-remitting multiple sclerosis
    Algahtani, Hussein
    Shirah, Bader
    Alqahtani, Abdulhadi
    Abdelghaffar, Nawal
    Makki, Samiah
    ACTA NEUROLOGICA BELGICA, 2024, 124 (01) : 303 - 306
  • [23] Evaluation of shorter infusion times with ocrelizumab in patients with relapsing-remitting multiple sclerosis
    Vollmer, Timothy
    Alvarez, Enrique
    Nair, Kavita
    Cohen, Jeffrey
    Boster, Aaron
    Masterman, Donna
    Pradhan, Ashish
    Musch, Bruno
    Ma, Xiaoye
    Pei, Jinglan
    Moss, Brandon
    Weinstock-Guttman, Bianca
    Bermel, Robert
    NEUROLOGY, 2019, 92 (15)
  • [24] Ocrelizumab modifies circulating immune asset in relapsing-remitting multiple sclerosis subjects
    Abbadessa, Gianmarco
    Bruzzaniti, Sara
    Miele, Giuseppina
    Piemonte, Erica
    Signoriello, Elisabetta
    Lus, Giacomo
    Matarese, Giuseppe
    Galgani, Mario
    Bonavita, Simona
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 21 - 21
  • [25] Relapsing-remitting and primary progressive multiple sclerosis treated with ocrelizumab: A comparative study
    de Antonio, Luis A. Rodriguez
    Cuberta-Gonzalez, Ines
    Garcia-Castanon, Inmaculada
    Oreja-Guevara, Celia
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 69
  • [26] The Effect of Rituximab on the Cognitive Function of Patients with Relapsing-Remitting Multiple Sclerosis
    Najafi, Masood
    Farahmand, Ghasem
    Balali, Pargol
    Behkar, Atefeh
    Shahbazi, Mojtaba
    Moradian, Negar
    Pouyanmanouchehri, Sara
    Harirchian, Mohammad Hossein
    Ranji, Sara
    CLINICAL THERAPEUTICS, 2024, 46 (10) : e1 - e5
  • [27] B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis
    Hauser, Stephen L.
    Waubant, Emmanuelle
    Arnold, Douglas L.
    Vollmer, Timothy
    Antel, Jack
    Fox, Robert J.
    Bar-Or, Amit
    Panzara, Michael
    Sarkar, Neena
    Agarwal, Sunil
    Langer-Gould, Annette
    Smith, Craig H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (07): : 676 - 688
  • [28] B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
    Dennis Bourdette
    Vijayshree Yadav
    Current Neurology and Neuroscience Reports, 2008, 8 (5) : 417 - 418
  • [29] Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis
    Roos, Izanne
    Sharmin, Sifat
    Malpas, Charles
    Ozakbas, Serkan
    Lechner-Scott, Jeannette
    Hodgkinson, Suzanne
    Alroughani, Raed
    Izquierdo, Guillermo
    Eichau Madueno, Sara
    Boz, Cavit
    van der Walt, Anneke
    Butzkueven, Helmut
    Buzzard, Katherine
    Skibina, Olga
    Foschi, Matteo
    Grand'Maison, Francois
    John, Nevin
    Grammond, Pierre
    Terzi, Murat
    Prevost, Julie
    Barnett, Michael
    Laureys, Guy
    Van Hijfte, Liesbeth
    Luis Sanchez, Jose
    Blanco, Yolanda
    Oh, Jiwon
    Mccombe, Pamela
    Ramo Tello, Cristina
    Soysal, Aysun
    Prat, Alexandre
    Girard, Marc
    Duquette, Pierre
    Yamout, Bassem I.
    Khoury, Samia
    Van Pesch, Vincent
    Macdonell, Richard
    Sa, Maria Jose
    Slee, Mark
    Kuhle, Jens
    Maimone, Davide
    Spitaleri, Daniele L. A.
    Willekens, Barbara
    Al-Asmi, Abdullah
    Robertson, Neil
    Coles, Alasdair
    Brown, J. William L.
    Kalincik, Tomas
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 629 - 631
  • [30] Rapid onset of ocrelizumab suppression of brain MRI activity in relapsing-remitting multiple sclerosis
    Barkhof, Frederik
    Kappos, Ludwig
    Bar-Or, Amit
    Li, David
    Belachew, Shibeshih
    Julian, Laura
    Sauter, Annette
    Stokmaier, Daniela
    Hauser, Stephen L.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP14 - NP15
12345